Inflammation and metabolism: the role of adiposity in sarcopenic obesity
-
G. M. Lynch; C. H. Murphy; E. M. Castro; H. M. Roche
Inflammation and metabolism: the role of adiposity in sarcopenic obesity Proc Nutr Soc
Publication Category: Basic Science
Emerging therapeutic potential for peptide YY for obesity-diabetes
- R. A. Lafferty; P. R. Flatt; N. Irwin Emerging therapeutic potential for peptide YY for obesity-diabetes Peptides
Adipokines and psoriasis: the obesity link
-
B. Kirby; M. Lynch
Adipokines and psoriasis: the obesity link Br J Dermatol
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity
-
H. Y. Kim; H. J. Lee; Y. J. Chang; M. Pichavant; S. A. Shore; K. A. Fitzgerald; Y. Iwakura; E. Israel; K. Bolger; J. Faul; R. H. DeKruyff; D. T. Umetsu
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity Nat Med
The esophagitis to adenocarcinoma sequence; the role of inflammation
-
M. E. Kavanagh; K. E. O'Sullivan; C. O'Hanlon; J. N. O'Sullivan; J. Lysaght; J. V. Reynolds
The esophagitis to adenocarcinoma sequence; the role of inflammation Cancer Lett
Opposing immune-metabolic signature in visceral versus subcutaneous adipose tissue in patients with adenocarcinoma of the oesophagus and the oesophagogastric junction
-
A. B. Heeran; J. McCready; M. R. Dunne; N. E. Donlon; T. S. Nugent; A. Bhardwaj; K. A. J. Mitchelson; A. M. Buckley; N. Ravi; H. M. Roche; J. V. Reynolds; N. Lynam-Lennon; J. O’sullivan
Opposing immune-metabolic signature in visceral versus subcutaneous adipose tissue in patients with adenocarcinoma of the oesophagus and the oesophagogastric junction Metabolites
Metabolomics in the developmental origins of obesity and its cardiometabolic consequences
-
M. F. Hivert; W. Perng; S. M. Watkins; C. S. Newgard; L. C. Kenny; B. S. Kristal; M. E. Patti; E. Isganaitis; D. L. DeMeo; E. Oken; M. W. Gillman
Metabolomics in the developmental origins of obesity and its cardiometabolic consequences J Dev Orig Health Dis
Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma
-
C. L. Donohoe; S. L. Doyle; S. McGarrigle; M. C. Cathcart; E. Daly; A. O'Grady; J. Lysaght; G. P. Pidgeon; J. V. Reynolds
Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma Br J Surg
Emerging Concepts Linking Obesity with the Hallmarks of Cancer
-
C. L. Donohoe; J. Lysaght; J. O'Sullivan; J. V. Reynolds
Emerging Concepts Linking Obesity with the Hallmarks of Cancer Trends Endocrinol Metab
MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review
- L. Dowling; A. Duseja; T. Vilaca; J. S. Walsh; K. Goljanek-Whysall MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review J Cachexia Sarcopenia Muscle